A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Different Doses of SLx-4090 in Combination With a Statin vs. Statin Mono-Therapy in Patients With Hyperlipidemia.
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2015
At a glance
- Drugs KD 026 (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Surface Logix
- 16 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Dec 2009 Actual patient number (133) added as reported by ClinicalTrials.gov.
- 16 Dec 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.